Help lower costs with biosimilars We actively promote evidence-based use of biosimilars to help you make the most of your integrated drug strategy. Breadcrumb Home Our solutions Condition...

publications High Cost Therapy Profile: January 2025 Tabelecleucel Intravenous (IV) Oncology January 8, 2025 Proposed indications Epstein-Barr virus-positive (EBV+) post-transplant...

Special Investigations Unit helps promote safety to prevent fraud, waste and abuse schemes

Expert Clinical Network Insights Hemophilia December 17, 2024 Medication insights: marstacimab-hncq (Hympavzi) The U.S. Food and Drug Administration (FDA) approved marstacimab-hncq (Hympavzi) in...

publications Drug Approvals: July 2024 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches July 31, 2024 Specialty New drugs Jun. 20,...

In this episode, our experts discuss Prime’s four primary tenets of practice for chronic weight management.

Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024

publications Drug Approvals: February 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches February 28, 2025 Specialty New drugs...

PUBLICATIONS FDA Decisions Expected: February 2025 Drug pipeline for February 2025 January 15, 2025 Your monthly synopsis of new drugs expected to hit the market At Prime Therapeutics (Prime), we...

PUBLICATIONS FDA Decisions Expected: May 2025 Your monthly synopsis of new drugs expected to hit the market April 14, 2025 Drug pipeline for May 2025 At Prime Therapeutics (Prime), we have...

Event features discussions about health care industry trends, best practices and innovations

Drug Approvals Monthly Update: August 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...

publications High-Cost Therapy Profile: May 2025 Vusolimogene oderparepvec Intratumoral | Replimune Oncology-Gene therapy May 15, 2025 Proposed indications Advanced melanoma FDA approval...

Reimagine your pharmacy benefit partner Designed by health plans for health plans, we provide an innovative pharmacy benefit manager (PBM) partnership experience. Breadcrumb Home Who we are About...

This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process.

This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process.

Drug Approvals Quarterly Update: July 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process. Prime...

Drug Approvals September 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and...

Drug Approvals Quarterly Update: January 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process....

publications Drug Approvals: December 2024 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches December 30, 2024 Specialty New drugs...

research 10 research posters presented by Prime at AMCP Nexus 2024 Studies include Prime’s GLP-1 obesity research, health equity, and real world case studies October 18, 2024 Evaluating the...

publications Drug Approvals: January 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches January 31, 2025 Specialty New drugs Dec....

Help your members take their health to the next level KeepWell™ offers a personalized and effective path to wellness, supporting members with obesity, diabetes, hypertension and high cholesterol....

Discover next-gen pharmacy solutions We deliver innovative pharmacy benefit management and a differentiated experience that puts customer and member needs first Breadcrumb Home Who we are About us...

Event features Prime experts

publications High-Cost Therapy Profile: April 2025 Deramiocel Intravenous (IV) | Nippon Shinyaku Co., Ltd./Capricor Therapeutics, Inc. Cardiovascular/Musculoskeletal April 15, 2025 Proposed...

2024 AMCP Annual Posters As presented at the 2024 Academy of Managed Care Pharmacy (AMCP) Annual Meeting. Click on the poster image to view the full-size version. Save: Making medications more...

Help your members on high-cost clinical drugs Our deep expertise and holistic view of patient care help you manage the most complex conditions and expensive specialty drugs across both pharmacy...

Formulary design recommendations help create competition to drive savings, provide optionality to meet unique client needs.

Annual meeting will feature industry research posters and educational sessions

Oncology Insights Oncology Case Management and Navigation: How do they differ? October 14, 2024 Caring for and treating a patient with cancer is complex. Many patients struggle to coordinate...

The SIU promotes safety to prevent fraud, waste and abuse schemes

In this special episode of the Pharmacy Friends podcast, “Live at Specialty Summit ’24 – Connect. Elevate. Transform.,” we are on the road in New York City at our 21st annual Specialty Summit. More...

Support members with autoimmune diseases We help members navigate their autoimmune diseases with our holistic, customized approach to care. Breadcrumb Home Our solutions Condition management...

Cover AMCP Prime Therapeutics /amcp-nexus-2024-research-posters 10 research posters presented by Prime at AMCP Nexus 2024 covers topics like GLP-1 obesity research, health equity initiatives, and...

Eyebrow High-Cost Therapy Profile: February Detailed information about Marnetegragene autotemcel Intravenous (IV) High Cost Therapy Profile Gene Therapy/Immunology Marnetegragene autotemcel...

Cover image for 8 research posters presented by Prime at the 2024 AMCP Annual Meeting 2024 AMCP Annual Meeting Prime Therapeutics /2024-amcp-annual-meeting-research-posters 8 research posters...

2024 AMCP Nexus Posters As presented at the 2024 Academy of Managed Care Pharmacy (AMCP) Nexus event. Click on the poster image to view the full-size version. Save: Making medications more...

Constant communication across the supply chain limits disruption when a drug is unavailable

publications High Cost Therapy Profile: December 2024 Remestemcel-L Intravenous (IV) Mesoblast Limited December 11, 2024 Autoimmune/immunology Proposed indications Treatment of...